WEAV
Weave Communications, Inc.6.98
+0.23+3.41%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Specialty medical leads growth; AI pricing detailed.
Q&A largely reaffirmed prepared remarks on Weave's AI road map and growth vectors, but spotlighted specialty medical as 2026's strongest grower amid maturing integrations. Management confidently outlined AI Receptionist monetization via location-based pricing linked to labor savings, without specifics. Churn in new vertical cohorts improved quarterly, not just yearly. Payments showed surcharging green shoots boosting volumes; competitors trail on telephony ownership and workflow depth. Scale and compliance set Weave apart. Investors watch AI upsell execution.
Key Stats
Market Cap
544.62MP/E (TTM)
-Basic EPS (TTM)
-0.45Dividend Yield
0%Recent Filings
10-K
FY2025 results
Weave drove FY2025 revenue to $239M, up 17% y/y, with locations surging 13% to 39,625 amid TrueLark acquisition momentum. Q4 accelerated growth as new locations fueled 69% of gains while existing sites added 31%, pushing subscription gross margins steady at 78%. Yet net loss held at $28M on $103M sales spend; free cash flow hit $13M. Liquidity strong at $81M cash/investments, $50M revolver available. No annual guidance disclosed. Customer churn risk could stall quarterly momentum.
8-K
Weave Q4 revenue up 17%
Weave reported Q4 revenue of $63.4 million, up 17.0% year-over-year, with full-year revenue hitting $239.0 million on identical growth. Gross margins expanded to 72.7% GAAP while non-GAAP operating income reached $2.3 million. Revenue grows steadily. Guides 2026 revenue to $273-276 million, non-GAAP operating income $8-12 million, yet TrueLark integration poses risks.
10-Q
Q3 FY2025 results
Weave posted Q3 revenue of $61.3M, up 17% y/y from $52.4M, with gross margin steady at 72%. Subscription and payments revenue—91% of total—grew 17% y/y to $58.8M at 78% gross margin, while onboarding and phone hardware dragged overall margins. Operating loss widened to $8.9M from $6.6M y/y due to 25% higher sales/marketing and 33% R&D spend on headcount and AI integration post-TrueLark buy. Cash hit $64.4M plus $15.9M short-term investments; $50M revolver undrawn with no debt. Free cash flow not disclosed in the 10-Q. TrueLark closed May 2025 for $35.9M (cash/stock/holdback), adding $29.5M goodwill and $8.0M intangibles (5-7 year lives). Competition from point solutions pressures SMB retention.
8-K
Q3 revenue up 17.1%
Weave reported Q3 revenue of $61.3 million, up 17.1% year over year, with non-GAAP operating income at $1.7 million and free cash flow hitting $5.0 million. Gross margins edged higher to 72.3% GAAP, yet retention slipped to 90% gross. Full-year revenue guidance: $238-239 million. TrueLark integration poses risks.
10-Q
Q2 FY2025 results
Weave Communications posted solid Q2 FY2025 results, with revenue climbing 16% year-over-year to $58.5M, fueled by new customer additions and steady expansion from existing ones, while gross margin edged up to 72% from 71% thanks to a richer mix of high-margin payments revenue. Operating loss narrowed slightly to $10.2M from $9.3M, but net loss held steady at $8.7M, with the gap to operating loss mainly from $9.3M in stock-based compensation. Free cash flow turned positive at $4.5M (derived), supported by $5.4M in operating cash flow minus $1.0M capex. The May 2025 acquisition of Vidurama (TrueLark) closed for $35.8M in cash and stock, adding $29.3M goodwill and $8.0M intangibles amortized over 5-7 years to bolster AI-driven automation. Liquidity remains robust with $44.7M cash, $33.2M short-term investments, and a $50M undrawn revolver under covenants met. Yet competition in SMB healthcare software intensifies, pressuring margins if rivals undercut on pricing.
IPO
Website
Employees
Sector
Industry
CCLD
CareCloud, Inc.
3.21+0.02
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.35+0.00
CRVW
Careview Communications, Inc.
0.02+0.00
DH
Definitive Healthcare Corp.
2.29-0.01
EHVVF
Ehave Inc.
0.00-0.00
PHR
Phreesia, Inc.
16.35-0.35
VEEV
Veeva Systems Inc.
219.30-0.80
VSEE
VSee Health, Inc.
0.45-0.02
WAY
Waystar Holding Corp.
32.90+0.34
WHTCF
Well Health Technologies Corp.
2.89+0.03